Reina Takeda, M.D., Ph. D., is a hematologist and currently a Research Fellow in Pediatric Oncology at Dana-Farber Cancer Institute (DFCI). After receiving her MD in Japan, she completed her clinical training in internal medicine and hematology/oncology. She received her PhD from the University of Tokyo in 2020 for her basic research on epigenetic dysregulation in myeloid malignancies and joined Dr. Scott Armstrong's lab at DFCI in 2022. Her clinical experience as a physician in Japan has inspired her to develop a deeper understanding of the pathogenesis and molecular biology of hematologic malignancies. Her research interests focus on how oncogenic proteins cause transcriptional dysregulation in hematologic malignancies and contribute to their pathogenesis. As a hematology/oncology physician-scientist, her research goal is to translate basic scientific knowledge from the bench to the bedside by identifying novel therapeutics that target key regulatory pathways.